Previous analysis using the Cancer Genome Atlas (TCGA) demonstrated that overexpression of AP1S3 is associated with poor outcomes in breast cancer, and the staining pattern of the AP1S3 products is similar to the scattered pattern of γ1-adaptin in this study [16]. This evidence concerns the gene AP1S3 and breast carcinoma.